De dosis Salbutamol (Ventolin) bij de reversibiliteitsmeting The doses Salbutamol (Ventolin) during the reversibility measurement
Recruiting
- Conditions
- COPD/Asthma
- Registration Number
- NL-OMON24962
- Lead Sponsor
- HagaZiekenhuis, locatie Leyweg
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 170
Inclusion Criteria
Age >18 years - < 80 years.
- Referral for diagnostic Asthma/COPD
Exclusion Criteria
- Use of Beta2-sympathicomimetica <6 hour prior to measurement.
Use of anticholinergica <12 hour prior to measurement.
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method FEV1 (L)
- Secondary Outcome Measures
Name Time Method FVC (L) en subjective dyspnea